Liu Zhi-Peng, Su Xing-Xing, Chen Long-Fei, Li Xue-Lei, Yang Yi-Shi, You Zhi-Long, Zhao Xiao-Lin, Huang Fan, Yu Chao, Wu Zhao-Ping, Chen Wei, Zhou Jin-Xue, Guo Wei, Yin Da-Long, Yue Ping, Ding Rui, Zhu Yi, Chen Wei, Jiang Yan, Bai Jie, Wang Jing-Jing, Zhang Yan-Qi, Zhang Dong, Dai Hai-Su, Lau Wan Yee, Chen Zhi-Yu
Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Hepato-pancreato-biliary Center, Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
Hepatobiliary Surg Nutr. 2024 Oct 1;13(5):788-800. doi: 10.21037/hbsn-23-518. Epub 2024 May 16.
Gallbladder cancer (GBC) was once considered a contraindication for laparoscopic surgery, but it is becoming more common to use laparoscopic surgery for GBC treatment. The aim of this study was to analyze the long- and short-term outcomes of patients with more advanced T-staged GBC treated with curative intent as defined by the National Comprehensive Cancer Network (NCCN) after laparoscopic resection (LR) versus open resection (OR).
A multicenter database was used to select consecutive GBC patients treated with curative-intent resection as defined by the NCCN between 2016 and 2020. The patients were divided into the LR group and the OR group. Propensity score matching (PSM) was used to eliminate selection bias. The endpoints were overall survival (OS), progression-free survival (PFS), and short-term outcomes. Risk factors that were independently associated with OS and PFS were identified.
Of 626 GBC patients treated with curative-intent resection, after PSM, 51 patients were in the LR group and 153 patients were in the OR group. The LR group had more patients who were suitable to receive adjuvant chemotherapy (AC), a longer operation time, more harvested lymph nodes, and a lower overall morbidity rate. The rates of OS and PFS were not significantly different between the two groups. AC was independently associated with better OS and PFS.
The overall morbidity of GBC patients after LR was lower, but the long-term outcomes between LR and OR were not significantly different. The GBC patients treated with LR were more likely to receive AC, and the use of AC after curative-intent resection of GBC helped achieve better long-term survival outcomes.
胆囊癌(GBC)曾被认为是腹腔镜手术的禁忌证,但目前使用腹腔镜手术治疗GBC越来越普遍。本研究的目的是分析按照美国国立综合癌症网络(NCCN)定义的具有治愈意图接受治疗的T分期较晚的GBC患者,在腹腔镜切除术(LR)与开放切除术(OR)后的短期和长期结局。
使用多中心数据库选择2016年至2020年间按照NCCN定义接受具有治愈意图切除术的连续性GBC患者。将患者分为LR组和OR组。采用倾向评分匹配(PSM)以消除选择偏倚。终点指标为总生存期(OS)、无进展生存期(PFS)和短期结局。确定与OS和PFS独立相关的危险因素。
在626例接受具有治愈意图切除术的GBC患者中,经PSM后,LR组有51例患者,OR组有153例患者。LR组中有更多患者适合接受辅助化疗(AC),手术时间更长,切除的淋巴结更多,总体发病率更低。两组的OS和PFS率无显著差异。AC与更好的OS和PFS独立相关。
LR后GBC患者的总体发病率较低,但LR和OR之间的长期结局无显著差异。接受LR治疗的GBC患者更有可能接受AC,且GBC具有治愈意图切除术后使用AC有助于实现更好的长期生存结局。